Abstract:Minitablets have been extensively studied in recent years as a convenient pediatric form because they allow successful administration even in very young children. Their advantages include easy dose adjustment by multiplication of single units as well as the possibility of drug release modification by coating or forming matrix systems. The aim of this study was to demonstrate the possibility of the formulation of prolonged-release minitablets with bromhexine hydrochloride (BHX) and bisoprolol fumarate (BFM) dedicated to pediatric patients. Minitablets with 3 mm diameter and 15 mg mass, containing 1 mg of active substance in 1 unit, were prepared by direct compression with hydroxypropyl methylcellulose (HPMC) of different grades, methylcellulose, sodium alginate, or polyvinyl alcohol (PVA) as a sustained-release polymer. Different amounts of polymers and different compression forces were evaluated. Analysis of minitablets included their uniformity, hardness, and dissolution tests. The kinetics of drug substance release were analyzed with dedicated software. The prepared minitablets met the pharmacopeial requirements with respect to the uniformity of mass and content. The compressibility of BFM was significantly better than that of BHX, yet all minitablets had good mechanical properties. Dissolution studies showed a strong relationship between the type of polymer and its amount in the mass of a tablet and the dissolution rate. Prolonged release of up to 8 h was achieved when HPMC of 4000 cP viscosity was used in the amount of 30% to 80%. Sodium alginate in the amount of 50% was also effective in prolonging dissolution, but PVA was much less effective. Studies on the release kinetics showed that dissolution from prolonged-release minitablets with BHX fit the best to Hopfenberg or Hixson–Crowell models, while in the case of BFM, the best fit was found for Hopfenberg or Korsmeyer–Peppas models.

Preparation and Evaluation of a Novel Delayed-Onset Sustained-Release System of Propranolol Hydrochloride

Preparation of Captopril Delayed-Onset, Sustained Release Tablets

Study on pramipexole dihydrochloride sustained-release tablets

Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride

Optimization of Gastroretentive Delayed Release Drug Delivery using Design of Experiment Approach

Preparation of Zhitong Sustained-Release Tablet and Its Release Property in Vitro

Preparation and optimization of sustained-release tablets of propafenone hydrochloride β-CD inclusion complex

Propranolol hydrochloride osmotic capsule with controlled onset of release

Formulation and Evaluation of Polysaccharide Microparticles for the Controlled Release of Propranolol Hydrochloride

Design and evaluation of a dry coated drug delivery system with floating-pulsatile release

Preparation and controlled release of mesoporous MCM-41/propranolol hydrochloride composite drug

Preparation of Levodropropizine Sustained Release Matrix Tablet and Its in Vitro Evaluation of Drug Release

Preparation and in Vitro Release of Nifedipine Delayed-Onset Sustained-Release Tablets

Preparation of Carteolol Hydrochloride Matrix Sustained-Release Pellets and Evaluation in Vitro/In Vivo

Design and Development of Propranolol HCl Fast Dissolving Tablets by Using Isolated Mucilage of Salvia Hispanica for the Treatment of Hypertension by Using DoE tools

[Preparation of Diltiazem Hydrochloride Delayed-Onset, Sustained Release Tablet].

Preparation and in vitro/in vivo evaluation of a clonidine hydrochloride drug–resin suspension as a sustained-release formulation

Design, formulation, and evaluation of delayed release oral dosage form of proton pump inhibitor

Application of Hydrophilic Polymers to the Preparation of Prolonged-Release Minitablets with Bromhexine Hydrochloride and Bisoprolol Fumarate

Application of Gray Absolute Degree of Incidence to Formulation Optimization of Delayed, Sustained-release Propranolol Hydrochloride Pellets

Preparation, Characterization and In Vitro / In Vivo Evaluation of Oral Time-Controlled Release Etodolac Pellets